Latest Articles
Frequently Searched Questions: Uterine Cancer - Roswell Park Comprehensive Cancer Center
Frequently Searched Questions: Uterine Cancer Roswell Park Comprehensive Cancer Center
Published: June 24, 2024, 7 a.m.
Take period pains seriously. It could be endometriosis - The Kathmandu Post
Take period pains seriously. It could be endometriosis The Kathmandu Post
Published: June 24, 2024, 7 a.m.
Why Tayla Williams believes netball is the perfect place to spark a conversation about endometriosis and periods - ABC News
Why Tayla Williams believes netball is the perfect place to spark a conversation about endometriosis and periods ABC News
Published: June 24, 2024, 7 a.m.
Pain of Endometriosis: Bungoma woman's journey for diagnosis and treatment - The Star Kenya
Pain of Endometriosis: Bungoma woman's journey for diagnosis and treatment The Star Kenya
Published: June 24, 2024, 7 a.m.
Sexual shame is an unspoken truth of endometriosis - but it shouldn't be - Cosmopolitan UK
Sexual shame is an unspoken truth of endometriosis - but it shouldn't be Cosmopolitan UK
Published: June 23, 2024, 7 a.m.
Out-of-action Bedford Hospital lifts lead to cancellations - BBC.com
Out-of-action Bedford Hospital lifts lead to cancellations BBC.com
Published: June 23, 2024, 7 a.m.
Lenvatinib/Pembrolizumab Misses OS End Points, But Still Shows Activity, in Advanced Endometrial Cancer - OncLive
Lenvatinib/Pembrolizumab Misses OS End Points, But Still Shows Activity, in Advanced Endometrial Cancer OncLive
Published: June 21, 2024, 7 a.m.
Olympic Figure Skater Tara Lipinski, 42, Had An 'Athlete Mindset' Amid Five-Year Struggle With Fertility, Which She Calls 'The Most Difficult Thing That I've Ever Encountered' - SurvivorNet
Olympic Figure Skater Tara Lipinski, 42, Had An 'Athlete Mindset' Amid Five-Year Struggle With Fertility, Which She Calls 'The Most Difficult Thing That I've Ever Encountered' SurvivorNet
Published: June 21, 2024, 7 a.m.
ROCSAN Study Step I Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma - OncLive
ROCSAN Study Step I Misses 16-Week ORR End Point in Endometrial or Ovarian Carcinosarcoma OncLive
Published: June 20, 2024, 7 a.m.
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer - Frontiers
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer Frontiers
Published: June 20, 2024, 7 a.m.
Link copied to clipboard!